M. Sidhu

发表

Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.

M. Gold, W. Abraham, S. Mealing, 2015, JACC. Heart failure.

Excess mortality, length of stay and cost attributable to candidaemia.

D. Denning, M. Sidhu, I. Hassan, 2009, The Journal of infection.

The cost‐effectiveness of solifenacin vs fesoterodine, oxybutynin immediate‐release, propiverine, tolterodine extended‐release and tolterodine immediate‐release in the treatment of patients with overactive bladder in the UK National Health Service

L. Cardozo, J. Warner, A. Thorpe, 2010, BJU international.

Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system

R. Launois, K. Le Lay, M. Sidhu, 2007, The European Journal of Health Economics.

Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany

I. Odeyemi, M. Sidhu, A. V. van Engen, 2008, Current medical research and opinion.

Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation

B. Tombal, A. Abou-Setta, I. Odeyemi, 2013, ClinicoEconomics and outcomes research : CEOR.

Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic Candida infections in the UK

M. Palazzo, M. Sidhu, A. V. van Engen, 2009, Current medical research and opinion.

Health‐related utility among adults with atopic dermatitis treated with 0·1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic® CONTROL study

C. Poole, C. Currie, M. Sidhu, 2009, The British journal of dermatology.

Analytical validation of a novel multi-analyte plasma test for lung nodule characterization

A. Wu, M. Sidhu, N. Trivedi, 2018, Biomedical research and reviews.

Twice‐weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 months

D. Thaçi, M. Sidhu, B. Ehlken, 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors.

J. Lipton, S. Lustgarten, N. Hawkins, 2015, Leukemia research.

Economics of cancer biomarkers.

J. Schneider, D. Chalfin, R. Ohsfeldt, 2012, Personalized medicine.

Economic evaluation of maintenance treatment with tacrolimus 0·1% ointment in adults with moderate to severe atopic dermatitis

A. Wollenberg, K. Berger, M. Schaff, 2008, The British journal of dermatology.

Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progression.

J. Tripodi, V. Najfeld, R. Hoffman, 2011, Cancer genetics.

Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up.

M. Gold, W. Abraham, S. Mealing, 2017, JACC. Heart failure.

Economic value and cost-effectiveness of biventricular versus right ventricular pacing: results from the BLOCK-HF study

A. Curtis, E. Chung, M. G. St. John Sutton, 2019, Journal of medical economics.

Long-Term Bone Marrow Suppression During Postoperative Chemotherapy in Rectal Cancer Patients After Preoperative Chemoradiation Therapy.

Ting Chen, Shou-En Lu, S. Jabbour, 2016, International journal of radiation oncology, biology, physics.

Twice‐weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 months

M. Sidhu, B. Ehlken, C. Chambers, 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

Clinicoeconomics and Outcomes Research

B. Tombal, A. Abou-Setta, I. Odeyemi, 2022 .